• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Enzon Pharmaceuticals Inc. (ENZN)

    -NasdaqCM
    0.96 Down 0.03(3.44%) Jan 30, 3:59PM EST
    Add to Portfolio
    Prev Close:1.00
    Open:0.99
    Bid:N/A
    Ask:1.21 x 500
    1y Target Est:14.00
    Beta:2.34
    Next Earnings Date:N/A
    Day's Range:0.95 - 0.99
    52wk Range:0.78 - 1.83
    Volume:162,211
    Avg Vol (3m):207,619
    Market Cap:42.50M
    P/E (ttm):1.49
    EPS (ttm):0.65
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ENZNDown 3.44%42.50M
    ISISDown 1.93%8.09B
    NKTRDown 2.79%1.88B
    PFEDown 1.82%196.90B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1.37
    Ex-Dividend Date:08-Jan-15

    Analysts

    Annual EPS Est (Dec-14) :N/A
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Enzon Pharmaceuticals, Inc. is engaged in licensing drug products. Its marketed drug products include PegIntron for chronic hepatitis C; Sylatron for Melanoma; Macugen for neovascular age-related macular degeneration; CIMZIA for Crohn’s disea... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback